Skip to main content
v2026.11,986 entries · CC-BY 4.0

CRMF (CASRAI)

Clinical Research Associate Training: Clinical Research Monitoring Foundation, CRMF (CASRAI)

Clinical trial monitoring training on ICH E6(R3), with no experience requirement: eight self-paced modules, then a 50-question exam for the CRMF (CASRAI) credential.

LevelFoundationCRMCRMF (CASRAI)
3 h
Nominal
Self-paced study
8
Lessons
Self-paced
6
Domains
Exam blueprint
50
Exam items
Per attempt
70%
Pass mark
Fixed, uncurved
90
Retake wait
Days
3 yr
Valid for
From the pass

What you earn

The credential itself

Pass the examination and CASRAI issues this certificate and the post-nominal CRMF (CASRAI), signed by the Programme Director, valid for 3 years, and checkable by anyone from the verification code on its face.

Specimen. Issued as a signed PDF and as a machine-readable Open Badge; the holder and code shown are illustrative.
How it appears on your CV

Certifications

CRMF (CASRAI) — Clinical Research Monitoring, Foundation

CASRAI·Issued Mar 2026·Credential ID CASRAI-CRM-2026-ROENHE

casrai.org/verify/CASRAI-CRM-2026-ROENHE

Every certificate is issued under the signature of Dr. Diana Nieves Castro, MD, Programme Director of CASRAI Certification, who sets the syllabus, blueprint and pass mark for this credential.

It certifies that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published on this page — and anyone can confirm it from the verification code, without an account and without contacting us.

About this credential

What it covers

Who this course is for

Clinical Research Monitoring — Foundation is for people who need to understand clinical trial monitoring and show that they do, before they have years of monitoring behind them:

  • clinical trial assistants, in-house CRAs (clinical research associates) and CRA trainees in their first months in a monitoring role;
  • people moving into monitoring from site coordination, nursing, pharmacy, laboratory science or data management;
  • site staff and investigators who are monitored and want to know what a monitor is actually required to check;
  • sponsor and CRO staff who read monitoring reports and act on escalations without performing visits themselves, such as study managers, central monitoring analysts and trial master file specialists.

“CRA” here means clinical research associate, the trial monitor. The course has nothing to do with research-administration credentials that use the same letters.

What you will be able to do

  • Explain what monitoring is for, using the ICH E6(R3) definitions, and tell monitoring apart from quality assurance, audit and inspection.
  • Identify where the duty to monitor comes from in the United States (21 CFR Parts 312 and 812), the European Union (Regulation (EU) No 536/2014) and the United Kingdom (the Medicines for Human Use (Clinical Trials) Regulations 2004 as amended).
  • Read a monitoring plan and map its activities to the monitoring activities E6(R3) describes, without mistaking industry visit conventions for ICH requirements.
  • Verify from the records that informed consent was obtained properly and before participation, and recognise consent defects.
  • Identify the source record for a data point, tell source data review from source data verification, and justify checking data on a sample.
  • Check investigational product accountability, storage and blinding, and classify adverse events, serious adverse events and suspected unexpected serious adverse reactions.
  • Recognise a protocol deviation, write findings that meet the E6(R3) requirements for monitoring reports, and route a finding to the right person.

The eight modules

  1. What monitoring is for. Monitoring as quality control; how it differs from quality assurance, audit and inspection; who may and may not monitor a site.
  2. Where the obligation comes from. Guidelines and regulations; the US, EU and UK rules that require sponsors to monitor; which rules apply to a given trial.
  3. The trial life cycle and the monitoring plan. Monitoring activities from site selection to close-out; on-site, remote and centralised monitoring; what a monitoring plan must contain.
  4. Verifying informed consent. Timing, approved versions, signatures and dates, delegation, legally acceptable representatives, impartial witnesses, and confidentiality when you handle identifiable records.
  5. Source records, source data review and source data verification. What counts as a source record, certified copies, data integrity, audit trails, and why data are checked on samples.
  6. Investigational product and safety. Accountability, storage and temperature excursions, blinding and unblinding, and adverse event classification.
  7. Deviations, findings and reports. Protocol deviations and important deviations, proportionate action, and writing a monitoring report that carries open findings forward.
  8. The oversight chain, and what a monitor does not do. Sponsor responsibility when monitoring is transferred to a CRO, escalation, noncompliance, and what to do when you suspect data manipulation.

The course is written against ICH E6(R3) Good Clinical Practice (Principles and Annex 1), with the national rules named above. You study at your own pace, and your access to the course does not expire.

The exam

  • 50 scored four-option multiple-choice questions, drawn for each attempt from a larger question bank in proportion to the six exam domains below.
  • Pass mark: 70%.
  • Must be finished within 4 hours of starting.
  • If you do not pass, you can retake the exam after 90 days.
  • You must complete all eight modules before you can start the exam.

Exam domains and weights: what monitoring is and where the obligation comes from (16%); the trial life cycle from the monitor’s seat (15%); consent verification and participant-protection checks (16%); source records, source data review and source data verification (20%); investigational product, safety and deviations (18%); reporting, escalation and the oversight chain (15%).

Eligibility

Foundation: there is no eligibility requirement. Anyone can enrol, with or without monitoring experience.

Professional (the next level, sold separately): at checkout you confirm that you meet one of these routes. CASRAI does not check documents.

  • 24 months’ experience in the last 8 years in monitoring or in sponsor-side oversight of monitoring (part-time counts pro rata; unpaid, academic-sponsor and investigator-initiated trial work counts); or
  • CRMF (CASRAI) plus 12 months of that experience; or
  • a current clinical research credential from a recognised professional body plus 12 months of that experience; or
  • a completed degree or postgraduate certificate in clinical research, clinical trials or a closely related field plus 12 months of that experience.

What the credential is, and what it is not

Passing the exam earns CRMF (CASRAI), an examined credential issued by CASRAI. Each certificate can be verified with CASRAI.

  • It is not accredited by any accreditation body.
  • It carries no continuing education credit (no CE, CME or CEU).
  • It does not meet any statutory, regulatory, funder, sponsor or institutional training requirement, including any GCP training an employer or sponsor requires.
  • It is not endorsed by any regulator, funder or professional body.
  • It is not the CCRA® or any other credential of the Association of Clinical Research Professionals (ACRP) or the Society of Clinical Research Associates (SOCRA), and it is not a substitute for them.
  • It does not authorise you to monitor a trial or to access source records. That authority comes from the sponsor that appoints you and from the trial agreements.

Validity and renewal

The credential is valid for 3 years from the date you pass. To renew it, you pass the then-current version of the exam again.

Price

US$119, paid once. The price covers the eight modules and the exam.

Body of knowledge

Exam blueprint

The exam is assembled to these weights on every attempt. They are published before purchase because a blueprint you cannot see is not a blueprint.

Domains and weights6 domains · 50 scored items
DomainWeight
What monitoring is, and where the obligation comes fromF1
16%8 items
The trial lifecycle from the monitor's seatF2
15%8 items
Consent verification and participant-protection checksF3
16%8 items
Source records, source data review and source data verificationF4
20%10 items
Investigational product, safety and deviationsF5
18%9 items
Reporting, escalation and the oversight chainF6
15%7 items
Total100%

Every attempt has this many items from each domain. The items themselves are drawn at random from the bank within those fixed per-domain quotas, so no two attempts are the same paper.

Syllabus

Syllabus: 8 lessons, 3 hours

Every lesson and every learning outcome is listed. The lesson bodies open on enrolment, and the exam opens once every lesson is marked complete.

8 lessons · 2.8 h

Lesson material opens once you are enrolled. The full syllabus and every learning outcome are shown here so you can judge the coverage before you pay.

  1. Lesson 1

    Module 1

    1 lesson · 30 min

    1. Locked.What monitoring is, and how it differs from audit and inspection30 min · Locked

      On completion you will be able to

      • State the purpose of monitoring in one paragraph using the section 3.11.4 aim and the Glossary definition.
      • Classify a described activity as monitoring, quality control, quality assurance, audit or inspection and justify the classification from the Glossary.
      • Explain why E6(R3) treats monitoring as a quality control activity and what follows for who performs it.
      • Decide, for a named person at a described site, whether the section 3.11.4 independence sentence allows them to monitor that site.
  2. Lesson 2

    Module 2

    1 lesson · 15 min

    1. Locked.Where the monitoring obligation comes from: US, EU and UK15 min · Locked

      On completion you will be able to

      • Distinguish a guideline from a regulation and explain how ICH GCP gains legal force in the US, the EU and the UK.
      • Cite the US drug and device, EU and UK provisions that require sponsors to monitor.
      • List the three trial characteristics Article 48 of Regulation (EU) No 536/2014 names for setting the extent of monitoring.
      • Determine, for a described trial, which national monitoring requirements apply.
  3. Lesson 3

    Module 3

    1 lesson · 15 min

    1. Locked.The trial life cycle and the monitoring plan15 min · Locked

      On completion you will be able to

      • Describe the section 3.11.4.5 monitoring activities across the trial life cycle.
      • Identify what section 3.11.4.3 requires a monitoring plan to contain and spot omissions in a sample plan.
      • Explain how the monitoring plan constrains what a monitor does (section 3.11.4.4).
      • Distinguish on-site, remote and centralised monitoring and state who may perform centralised monitoring.
      • Name the industry visit convention and state that ICH does not prescribe it.
  4. Lesson 4

    Module 4

    1 lesson · 15 min

    1. Locked.Verifying informed consent15 min · Locked

      On completion you will be able to

      • Verify from a document set that consent was obtained and documented before participation.
      • Identify common consent defects and classify each as correctable by documented follow-up or not correctable after the fact.
      • Determine when an impartial witness or a legally acceptable representative is required and what each must do.
      • Decide whether a protocol change requires participants to be re-consented under section 2.8.2.
      • Apply the monitor's confidentiality obligations when viewing identifiable source records on-site or remotely.
  5. Lesson 5

    Module 5

    1 lesson · 30 min

    1. Locked.Source records, source data review and source data verification30 min · Locked

      On completion you will be able to

      • Identify the source record for each data point in a described data flow.
      • Distinguish source data review from source data verification and state that neither is an ICH-defined term.
      • Explain, citing section 3.11.4.5.4(b), why data are checked on samples and when the sample should change.
      • Decide whether a copy meets the Glossary definition of a certified copy.
      • Apply the E6(R3) data-integrity attributes and distinguish them from the EMA ALCOA++ list.
  6. Lesson 6

    Module 6

    1 lesson · 30 min

    1. Locked.Investigational product and safety30 min · Locked

      On completion you will be able to

      • Perform an investigational product accountability check against section 3.11.4.5.3(a).
      • Determine the correct handling of a storage temperature excursion and who decides whether product may be used.
      • Identify a blinding risk at a site and the documentation required after premature unblinding.
      • Classify an event as an adverse event, serious adverse event or SUSAR using the Glossary criteria.
      • Identify an adverse event present in a source record and missing from the reported data.
  7. Lesson 7

    Module 7

    1 lesson · 15 min

    1. Locked.Deviations, findings and monitoring reports15 min · Locked

      On completion you will be able to

      • Identify a protocol deviation and decide whether the sponsor's section 3.9.3 criteria make it important.
      • Distinguish a protocol deviation from an adverse event when both appear in the same facts.
      • Draft the significant-findings section of a monitoring report that meets section 3.11.4.6(a), including carry-forward.
      • Distinguish an observation, a finding and an action.
      • Choose an action proportionate to a deviation's importance (section 3.11.4.5.1(d)).
  8. Lesson 8

    Module 8

    1 lesson · 15 min

    1. Locked.The oversight chain, and what a monitor does not do15 min · Locked

      On completion you will be able to

      • State who is accountable when monitoring has been transferred to a CRO, and why.
      • Route a finding through the correct escalation path.
      • Decide whether described noncompliance meets the section 3.12.2 threshold for serious noncompliance.
      • Identify the point at which a monitoring matter stops being one, and what the monitor must not do then.

Assessment

How the exam works

The exam is closed-book and multiple choice. Each attempt draws a fresh form to the domain weights above, so no two attempts are the same paper and no answer key circulates. The pass mark is 70% and is fixed — there is no curve, no quota and no adjustment by cohort.

Scoring is immediate. Pass, and every item is reviewed with the option you chose, the correct option and its rationale. If you do not pass, you see your overall score and your score per domain (smaller domains are grouped together); which items you missed, and their answers, are held back so your resit is still a real assessment. A failed attempt may be retaken after 90 days. The wait exists so a retake is a second attempt at the material rather than a second attempt at remembering the paper.

The exam opens once you have marked every lesson of the course complete. Forms are assembled to the blueprint above or not at all: where a domain cannot yet be sampled to that standard, the exam declines to start rather than issue an unbalanced paper. Your material and progress are never affected, and there is no time limit on when you sit.

Passing candidates are issued a certificate with a verification code, valid for 3 years from the date of the pass. Anyone can check that code on our public verification page without an account and without contacting us. To renew, pass the current examination again: renewal opens 180 days before the certificate expires, and a pass issues a renewed certificate valid for a further 3 years from that date.

Certifying authority

Signed by Dr. Diana Nieves Castro, MD

CASRAI’s certification programme is academically and medically directed by Dr. Diana Nieves Castro, MD, Programme Director, who sets the syllabus and blueprint for this credential and signs every certificate issued under it.

CASRAI has maintained the terminology and reporting standards of research administration for over a decade. It assumed leadership of the CRediT contributor-roles taxonomy in 2014 and carried it through to adoption as ANSI/NISO Z39.104-2022, now in use by publishers, funders and institutions worldwide. This examination is drawn from that body of work.

What the credential certifies: that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published above. It is valid for 3 years, and anyone can check it from the verification code on its face.

The ladder

Other levels of Clinical Research Monitoring

Levels are independent purchases. There is no prerequisite chain — sit whichever level matches the work you already do.

All CASRAI credentials

Common questions

Clinical Research Associate Training: Clinical Research Monitoring Foundation, CRMF (CASRAI): common questions

How to get into being a CRA?

Clinical Research Monitoring Foundation is written for CRA trainees and for people moving into monitoring from site coordination, nursing, pharmacy, laboratory science or data management. It has no experience prerequisite, so a career changer can enrol and show examined monitoring knowledge early. The credential does not itself authorise anyone to monitor a trial; that comes from the sponsor that appoints the monitor.

How long does it take to become a clinical research associate?

The Clinical Research Monitoring Foundation course is eight lessons with about 3 hours of study, taken at your own pace because course access does not expire. You must complete all lessons before starting the exam, and the exam must be finished within 4 hours of starting it. Becoming a working CRA also depends on being hired and appointed by a sponsor or CRO.

Is CRMF (CASRAI) the same as the CCRA certification?

No. The CCRA is a credential of the Association of Clinical Research Professionals (ACRP). CRMF (CASRAI) is a separate examined credential issued by CASRAI; it is not an ACRP credential and is not a substitute for the CCRA.

What does the CRMF (CASRAI) exam cover?

The exam is an online, multiple-choice test of 50 items with four options each, drawn from the course question bank across six weighted domains, with options shuffled. The domains are what monitoring is and where the obligation comes from (16%), the trial lifecycle (15%), consent verification (16%), source records, source data review and verification (20%), investigational product, safety and deviations (18%), and reporting, escalation and the oversight chain (15%). The pass mark is 70%, the exam must be completed within 4 hours of starting and is not proctored, and a failed attempt can be retaken after a 90-day waiting period.

How much does CRA training cost?

Clinical Research Monitoring Foundation costs US$119, a one-time card payment through Stripe checkout that covers the eight-lesson course and the CRMF (CASRAI) exam. Course access does not expire. The certificate is valid for 3 years, can be checked on a public verification page at casrai.org/verify, and is renewed by passing the current exam again, with the renewal window opening 180 days before expiry.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →